# FDA Inspection 1209301 - Ravi Ganeshappa, M.D. - June 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/ravi-ganeshappa-md/9ab0b31a-c041-4e4f-8dcc-3b659a91f353
Source feed: FDA_Inspections

> FDA Inspection 1209301 for Ravi Ganeshappa, M.D. on June 30, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209301
- Company Name: Ravi Ganeshappa, M.D.
- Inspection Date: 2023-06-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/ravi-ganeshappa-md/a42464aa-4b1f-462b-a29e-a93dbf5326db

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c